Inactive Instrument
Immune Pharmaceuticals, Inc. Share Price
Stocks
FZRQ
US45254C2008
Pharmaceuticals
OTC Markets Traded| 1 day | +300.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Devin J. Shaw
DFI | Director of Finance/CFO | 39 | 12/04/2021 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 10/12/2017 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Sidransky
BRD | Director/Board Member | 66 | 25/08/2013 |
Tony Fiorino
CHM | Chairman | 58 | - |
John A. Neczesny
BRD | Director/Board Member | 62 | 01/02/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/02/20 | Sell | Director | 75,000 | 0.0412% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +300.00% | -.--% | - | - | 386K | |
| -2.54% | +1.31% | +54.27% | +117.14% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.05% | 635B | |
| +0.16% | +0.08% | +25.29% | +96.64% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.55% | 378B | |
| -1.34% | -0.47% | +66.04% | +40.18% | 358B | |
| -0.68% | +2.65% | +22.98% | +49.15% | 295B | |
| -1.20% | +3.04% | +2.33% | +21.60% | 266B | |
| -1.79% | +1.57% | +50.56% | +61.40% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.06% | 193B | |
| Average | +29.01% | +2.17% | +37.02% | +69.31% | 444.85B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +80.33% |
Employees
7
Sector
Pharmaceuticals
